Marc Belsky
2014 - Five Prime Therapeutics
In 2014, Marc Belsky earned a total compensation of $671.7K as Senior Vice President and Chief Financial Officer at Five Prime Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $131,300 |
|---|---|
| Option Awards | $240,378 |
| Salary | $300,000 |
| Total | $671,678 |
Belsky received $300K in salary, accounting for 45% of the total pay in 2014.
Belsky also received $131.3K in non-equity incentive plan and $240.4K in option awards.
Rankings
In 2014, Marc Belsky's compensation ranked 9,218th out of 13,032 executives tracked by ExecPay. In other words, Belsky earned more than 29.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,218 out of 13,032 | 29th |
Division Manufacturing | 3,459 out of 4,965 | 30th |
Major group Chemicals And Allied Products | 1,170 out of 1,690 | 31st |
Industry group Drugs | 928 out of 1,369 | 32nd |
Industry Pharmaceutical Preparations | 710 out of 1,042 | 32nd |
Source: SEC filing on March 31, 2017.
Belsky's colleagues
We found two more compensation records of executives who worked with Marc Belsky at Five Prime Therapeutics in 2014.